By Zack Lynch From this month’s Neurotech Insights investment newsletter focused on the depression market: While drugs to treat depression have proven effective for millions of individuals there exist a significant number of patients who do not respond to antidepressants. Treatment resistant depression, or refractory depression, is a condition that affects an estimated 4 million [...]